Corporate Overview

Ivy Sports Medicine ("ISM") was formed in February of 2011 to create a global healthcare company focused on providing the best sports medicine therapies for orthopedic surgeons and patients. In June 2011, ISM acquired assets from ReGen Biologics out of Chapter 11.

Our Mission

To build a global company that creates value for our employees, shareholders and stakeholders
by collaborating with practitioners in an open, responsive and ethical manner to foster
innovative products catering to the needs of sports medicine patients and physicians on an
economic basis

Our Strategy

Develop simple, comprehensive, data-driven therapies which enable sports medicine surgeons
to restore patient mobility.